单细胞分析揭示局限性硬皮病与系统性硬化症纤维化的不同机制
研究比较局限性硬皮病(LoS)与系统性硬化症(SSc)皮肤活检,发现LoS中三级淋巴结构(TLS)高发(65.7% vs SSc 14.3%,P=0.0013),Tfh细胞经CXCL13/CXCR5轴促进B细胞募集。SSc成纤维细胞高表达CREB3L1,过表达增加I型胶原等,敲低减轻小鼠皮肤和肺纤维化。结论提示LoS由TLS局部免疫驱动,SSc与CREB3L1成纤维细胞系统激活相关。
要点
- LoS病变TLS阳性率65.7%显著高于SSc的14.3%(P=0.0013)。
- LoS中Tfh细胞经CXCL13/CXCR5轴促进B细胞募集并维持TLS。
- SSc成纤维细胞CREB3L1过表达增加I型胶原、纤连蛋白1和骨膜蛋白。
核心结论
- LoS纤维化由TLS介导的局部免疫激活驱动,SSc纤维化与CREB3L1表达成纤维细胞的系统激活相关。
- 靶向局部炎症可能使LoS获益,靶向CREB3L1是SSc有前景的抗纤维化策略。
研究设计与样本
- 研究纳入3例健康对照、3例LoS和3例SSc的皮肤活检进行免疫荧光和单细胞RNA测序(scRNA-seq)。
- 关键分子功能通过体外实验和鼠模型验证。
主要发现
- 免疫荧光显示LoS病变TLS比例为65.7%,SSc为14.3%(P=0.0013)。
- scRNA-seq发现LoS的TLS中富集Tfh细胞,可能经CXCL13/CXCR5轴促进B细胞募集,整合素α4可能支持Tfh细胞滞留。
- SSc病变成纤维细胞高表达CREB3L1,过表达增加I型胶原、纤连蛋白1和骨膜蛋白,敲低则降低。
- SSc小鼠模型中CREB3L1上调加重皮肤和肺纤维化,敲低则减轻。
临床怎么用
- LoS治疗可考虑针对局部炎症和TLS相关免疫激活。
- SSc抗纤维化治疗可探索靶向CREB3L1表达成纤维细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Localized scleroderma (LoS) and systemic sclerosis (SSc) are both fibrotic diseases, but LoS is limited to the skin, whereas SSc involves systemic organ fibrosis. This study aimed to elucidate the mechanisms underlying these differences. METHODS: Skin biopsies from three healthy controls, three patients with LoS, and three patients with SSc underwent immunofluorescence and single-cell RNA sequencing (scRNA-seq). Key molecular functions were validated using in vitro assays and murine models. RESULTS: Immunofluorescence revealed a high prevalence of tertiary lymphoid structures (TLS) in LoS lesions (65.7%) compared with SSc (14.3%, P = 0.0013). scRNA-seq identified T follicular helper (Tfh) cells enriched within TLS in LoS. Tfh cells likely promote B cell recruitment via the CXCL13/CXCR5 axis, and integrin α4 may support Tfh cell retention, contributing to TLS stability. These organized immune aggregates, together with elevated transforming growth factor β (TGF-β) expression, may drive localized fibroblast activation and skin fibrosis in LoS. In contrast, SSc lesions contained fibroblasts with high CREB3L1 expression. CREB3L1 overexpression increased Type I collagen, fibronectin 1, and periostin levels in fibroblasts, whereas knockdown reduced them. In a SSc mouse model, CREB3L1 upregulation worsened skin and lung fibrosis, whereas knockdown alleviated it. CONCLUSION: These findings suggest that LoS fibrosis is driven by TLS-mediated local immune activation, whereas the systemic activation of CREB3L1-expressing fibroblasts plays an important role in SSc fibrosis. Targeting local inflammation may benefit LoS, whereas targeting CREB3L1 offers a promising antifibrotic strategy in SSc.
引用
- Huang J, Han X, Wang X, et al. Single-Cell Profiling Reveals Divergent Mechanisms of Fibrosis in Localized Scleroderma and Systemic Sclerosis. Arthritis Rheumatol. 2026. PMID: 41451447. doi:10.1002/art.70039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。